Y-mabs enters into partnership with Uruguayan firm to launch cancer drugs in South America

Danish biotech firm Y-mabs Therapeutics has closed a Latin American distribution contract for the company's two cancer drugs.

Photo: Kelly Davidson Photography

Y-mabs Therapeutics has found distribution partners in South America for its two pediatric cancer drugs.

The company, which is led by Genmab founder Claus Møller and partly owned by Joe & the Juice founder Kasper Basse, has signed a partnership deal with Adium Pharma concering the launch of naxitamab and ombutramab in 18 Latin American markets.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs